101 related articles for article (PubMed ID: 18591612)
1. Cytotoxic effect of drugs eluted from polymethylmethacrylate on stromal giant-cell tumour cells: an in vitro study.
Savadkoohi DG; Sadeghipour P; Attarian H; Sardari S; Eslamifar A; Shokrgozar MA
J Bone Joint Surg Br; 2008 Jul; 90(7):973-9. PubMed ID: 18591612
[TBL] [Abstract][Full Text] [Related]
2. Methotrexate eluted from bone cement: effect on giant cell tumor of bone in vitro.
Kirchen ME; Menendez LR; Lee JH; Marshall GJ
Clin Orthop Relat Res; 1996 Jul; (328):294-303. PubMed ID: 8653971
[TBL] [Abstract][Full Text] [Related]
3. Local recurrence of giant cell tumor of bone after intralesional treatment with and without adjuvant therapy.
; Becker WT; Dohle J; Bernd L; Braun A; Cserhati M; Enderle A; Hovy L; Matejovsky Z; Szendroi M; Trieb K; Tunn PU
J Bone Joint Surg Am; 2008 May; 90(5):1060-7. PubMed ID: 18451399
[TBL] [Abstract][Full Text] [Related]
4. Bisphosphonates induce apoptosis of stromal tumor cells in giant cell tumor of bone.
Cheng YY; Huang L; Lee KM; Xu JK; Zheng MH; Kumta SM
Calcif Tissue Int; 2004 Jul; 75(1):71-7. PubMed ID: 15037971
[TBL] [Abstract][Full Text] [Related]
5. Does the addition of cement improve the rate of local recurrence after curettage of giant cell tumours in bone?
Gaston CL; Bhumbra R; Watanuki M; Abudu AT; Carter SR; Jeys LM; Tillman RM; Grimer RJ
J Bone Joint Surg Br; 2011 Dec; 93(12):1665-9. PubMed ID: 22161931
[TBL] [Abstract][Full Text] [Related]
6. Recurrence of curetted and bone-grafted giant-cell tumours with and without adjuvant phenol therapy.
Trieb K; Bitzan P; Lang S; Dominkus M; Kotz R
Eur J Surg Oncol; 2001 Mar; 27(2):200-2. PubMed ID: 11289759
[TBL] [Abstract][Full Text] [Related]
7. Phenol as an adjuvant for local control in the treatment of giant cell tumour of the bone.
Dürr HR; Maier M; Jansson V; Baur A; Refior HJ
Eur J Surg Oncol; 1999 Dec; 25(6):610-8. PubMed ID: 10556009
[TBL] [Abstract][Full Text] [Related]
8. Functional results after giant cell tumor operation near knee joint and the cement radiolucent zone as indicator of recurrence.
Kafchitsas K; Habermann B; Proschek D; Kurth A; Eberhardt C
Anticancer Res; 2010 Sep; 30(9):3795-9. PubMed ID: 20944172
[TBL] [Abstract][Full Text] [Related]
9. Local Adjuvant Substances Following Curettage of Bone Tumors.
Bickels J; Campanacci DA
J Bone Joint Surg Am; 2020 Jan; 102(2):164-174. PubMed ID: 31613863
[No Abstract] [Full Text] [Related]
10. Surgical treatment of giant cell tumour of long bone with anhydrous alcohol adjuvant.
Oh JH; Yoon PW; Lee SH; Cho HS; Kim WS; Kim HS
Int Orthop; 2006 Dec; 30(6):490-4. PubMed ID: 16736146
[TBL] [Abstract][Full Text] [Related]
11. Retrospective analysis of 51 intralesionally treated cases with progressed giant cell tumor of the bone: local adjuvant use of hydrogen peroxide reduces the risk for tumor recurrence.
Omlor GW; Lange J; Streit M; Gantz S; Merle C; Germann T; Mechtersheimer G; Fellenberg J; Lehner B
World J Surg Oncol; 2019 Apr; 17(1):73. PubMed ID: 31014317
[TBL] [Abstract][Full Text] [Related]
12. Bisphosphonate-loaded Bone Cement as a Local Adjuvant Therapy for Giant Cell Tumor of Bone: A 1 to 12-Year Follow-up Study.
Greenberg DD; Lee FY
Am J Clin Oncol; 2019 Mar; 42(3):231-237. PubMed ID: 30811352
[TBL] [Abstract][Full Text] [Related]
13. Giant cell tumor of bone: risk factors for recurrence.
Klenke FM; Wenger DE; Inwards CY; Rose PS; Sim FH
Clin Orthop Relat Res; 2011 Feb; 469(2):591-9. PubMed ID: 20706812
[TBL] [Abstract][Full Text] [Related]
14. Giant cell tumor of bone. Curettage and cement reconstruction.
Bini SA; Gill K; Johnston JO
Clin Orthop Relat Res; 1995 Dec; (321):245-50. PubMed ID: 7497676
[TBL] [Abstract][Full Text] [Related]
15. Re-operation results in osteoarthritic change of knee joints in patients with giant cell tumor of bone.
Suzuki Y; Nishida Y; Yamada Y; Tsukushi S; Sugiura H; Nakashima H; Ishiguro N
Knee; 2007 Oct; 14(5):369-74. PubMed ID: 17601737
[TBL] [Abstract][Full Text] [Related]
16. Soft tissue extension increases the risk of local recurrence after curettage with adjuvants for giant-cell tumor of the long bones.
van der Heijden L; van de Sande MA; Dijkstra PD
Acta Orthop; 2012 Aug; 83(4):401-5. PubMed ID: 22880716
[TBL] [Abstract][Full Text] [Related]
17. Subchondral giant-cell tumor of the proximal tibia: arthroscopic treatment for accelerated articular cartilage and meniscal degeneration in two patients.
Tejwani SG; Hame SL; Eckardt JJ
Arthroscopy; 2004 Jul; 20(6):644-9. PubMed ID: 15241319
[TBL] [Abstract][Full Text] [Related]
18. Treatment of stages 2 and 3 giant-cell tumor.
Labs K; Perka C; Schmidt RG
Arch Orthop Trauma Surg; 2001; 121(1-2):83-6. PubMed ID: 11195127
[TBL] [Abstract][Full Text] [Related]
19. Contemporary adjuvant polymethyl methacrylate cementation optimally limits recurrence in primary giant cell tumor of bone patients compared to bone grafting: a systematic review and meta-analysis.
Zuo D; Zheng L; Sun W; Fu D; Hua Y; Cai Z
World J Surg Oncol; 2013 Jul; 11():156. PubMed ID: 23866921
[TBL] [Abstract][Full Text] [Related]
20. The influence of adjuvants on local recurrence rate in giant cell tumour of the bone.
Pietschmann MF; Dietz RA; Utzschneider S; Baur-Melnyk A; Jansson V; Dürr HR
Acta Chir Belg; 2010; 110(6):584-9. PubMed ID: 21337837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
